Harbour BioMed and Utrecht University licensed their fully human SARS-CoV-2 neutralizing antibody, 47D11, and its clinical program to AbbVie.
Apple Orders 30% iPhone Production Ramp, Signaling "Bright" Outlook With American Economy Still In Shambles Tyler Durden Tue, 12/15/2020 - 08:20 Apple disappointed Wall Street in...
Favorable updates on potential COVID-19 vaccines have been a major catalyst for stock market movements in recent months. Both Pfizer and Moderna have been grabbing headlines...
With limits on family time this Christmas, are we going to supplement Christmas spirit with presents?
Credit: ATS Dec. 15, 2020– In a new research letter published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine, researchers...
Switzerland’s Roche Holding AG announced that the US Food and Drug Administration (FDA) has approved a shorter two-hour infusion time for its multiple sclerosis (MS) treatment...
A study performed at one of the Research Centers supported by FAPESP resulted in development of a novel rehabilitation device. The article was recognized as outstanding...
With 2020 set to bring the curtain down on a biotech IPO boom unlike anything we’ve seen before, you have to wonder which companies are setting...
Novartis/Incyte’s Jakafi (ruxolitinib) looks unlikely to be added to the list of therapies that can be used against The post Novartis/Incyte draw blank with Jakafi in...
Markets have been turning mostly up since the election, as investors have taken the measure of the macro environment and appear pleased. There is some expectation...
Being nostalgic about the past can lead to a sense of loss in tough times.
Clinical trial at Moores Cancer Center at UC San Diego Health individualizes TIL therapy for patients with melanoma or head and neck cancers Credit: UC San...
Combination was uncovered from examining 12 potential drug candidates with over 530,0000 possible drug combinations within two weeks Credit: National University of Singapore A team of...
Biogen has filed a new drug application to Japan’s regulator for the approval of aducanumab, its investigational treatment for Alzheimer’s disease, which it is developing together...
How can students with special education needs be supported when learning remotely? This question plus management of COVID-19 in the workplace, yoga to relieve pandemic stress,...
Paul Peter Tak has done it all: From a professorship in his native Netherlands to the head of immunoInflammation R&D at GlaxoSmithKline, from leading small biotechs...
At this week’s annual meeting of the American Society of Hematology, Bluebird Bio announced favorable updates related to its gene therapy for sickle cell disease (SCD)....
On Wall Street, it’s out with tech and mega-caps and in with small-caps, cyclicals and value. Investors have been rotating away from the big names that...
By now, it appears that drug hunters have exploited just about every therapeutic angle having to do with RNA. Leveraging RNA as a therapy? Check. Making...
Harry Destecroix co-founded Ziylo while studying for his PhD at the University of Bristol. Ziylo, a university spin-out company, developed a synthetic molecule allowing glucose to...
We could start making our genomes equipped to deal with more frequent pandemics. But it may come at a cost.
We could start making our genomes equipped to deal with more frequent pandemics. But it may come at a cost.
Gilead Sciences disclosed that the results from the Phase 1b trial of its investigational antibody therapy, magrolimab, used for previously untreated acute myeloid leukemia (AML) patients,...
Syros Pharmaceuticals announced the acquisition of a clinical-stage drug candidate for Acute Promyelocytic Leukemia (or APL) from Orsenix, LLC. Syros (SYRS) has acquired from Orsenix all...
US Reports Record COVID Hospitalizations, 20K+ Patients In ICU: Live Updates Tyler Durden Sun, 12/06/2020 - 20:55 Summary: US ICU patients top 20K Azar says vaccines...
NJ Reports Record 6K New COVID Cases; US Tops 200K For 4th Straight Day: Live Updates Tyler Durden Sun, 12/06/2020 - 13:05 Summary: Azar says vaccines...
Shares of BioCryst Pharmaceuticals spiked 19% after the biotech company won US regulatory approval for Orladeyo, (berotralstat), its lead drug candidate for the prevention of attacks...
As Eli Lilly continues to build out data for their FDA-authorized Covid-19 treatment bamlanivimab, they’ve been seeking new partners to conduct more trials. And the pharma...
Jennifer Doudna PhD, the UC Berkeley biochemist who shared the 2020 Nobel Prize in Chemistry with Emmanuelle Charpentier PhD, was the recent guest of honor for...
The COVID-19 pandemic has caused one of the largest economic downturns since the Great Depression, resulting in financial uncertainty for many Americans. Q3 2020 hedge fund...